My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

256.56 -35.86 (-12.26%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Thoughts For Thursday: All Eyes On The CPI ↗

January 12, 2023

All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the...

Via Talk Markets

Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023

January 06, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference

January 04, 2023

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says ↗

December 07, 2022

Via Benzinga

Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference

October 31, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad Reports Third-Quarter 2022 Financial Results

October 27, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022

October 17, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely ↗

October 11, 2022

One analyst doubts any deal could come to fruition. If it did, it would make sense.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Friday ↗

October 28, 2022

During Friday, 125 stocks hit new 52-week lows.

Via Benzinga

Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11 ↗

October 11, 2022

Reuters US-China Chip War: KLA Relaxes Chip Supply To China

Via Benzinga

Bio-Rad Laboratories, Qiagen Mull Merger Of Equals ↗

October 11, 2022

Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.

Via Benzinga

Bio-Rad Acquires Curiosity Diagnostics

August 03, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Bio-Rad Laboratories: Q2 Earnings Insights ↗

July 28, 2022

Bio-Rad Laboratories (NYSE:BIO) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Bio-Rad Reports Second-Quarter 2022 Financial Results

July 28, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Tesla, Danaher And Some Other Big Gainers From Yesterday ↗

July 22, 2022

U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session ↗

July 21, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...

Via Benzinga

Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022

July 18, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Jim Cramer Says This Stock Is 'Too Risky' ↗

July 01, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Cadre Holdings Inc (NYSE: CDRE) as it "makes things, does stuff, sells at a profit, gives you money back."

Via Benzinga

Bio-Rad Publishes Corporate Sustainability Report

June 27, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

7 Profitable Places to Hide Your Money During a Bear Market ↗

May 13, 2022

With an imminent bear market on the horizon, investors are searching for alternative investment paths for diversification.

Via InvestorPlace

5 Value Stocks To Watch In The Healthcare Sector ↗

May 02, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

Recap: Bio-Rad Laboratories Q1 Earnings ↗

April 28, 2022

Bio-Rad Laboratories (NYSE:BIO) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Bio-Rad Reports First-Quarter 2022 Financial Results

April 28, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022

April 18, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

Will Investment Gains For Google Parent Reverse In Upcoming Earnings Report? ↗

April 05, 2022

Investment gains have played a big role in earnings beats for GOOGL stock in recent years but that may reverse in its first-quarter earnings.

Via Investor's Business Daily

Overview Of Value Stocks In The Healthcare Sector ↗

March 28, 2022

What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...

Via Benzinga

Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead ↗

March 10, 2022

We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.

Via InvestorPlace

Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day

February 25, 2022

From Bio-Rad Laboratories, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.